<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01189721</url>
  </required_header>
  <id_info>
    <org_study_id>3-2010-0102</org_study_id>
    <nct_id>NCT01189721</nct_id>
  </id_info>
  <brief_title>Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery</brief_title>
  <official_title>Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <brief_summary>
    <textblock>
      The investigators hypothesize that propofol infusion during surgery can affect the
      remifentanil hyperalgesia compared to sevoflurane inhalation.The outcome will be measured by
      a verbal numerical rating score (VNRS) and mechanical punctuating pain by electronic von frey
      filament.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">July 2011</completion_date>
  <primary_completion_date type="Anticipated">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tactile pain thresholds adjacent to the surgical wound assessed by von Frey hair before the induction and at postoperative 24 &amp; 48 hrs</measure>
    <time_frame>postoperative 48 hrs</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Remifentanil will be infused intraoperatively at 0.2 ㎍/㎏/min. patients who are in this group will be infused propofol intraoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Remifentanil will be infused intraoperatively at 0.2 ㎍/㎏/min. patients included this group will be inhaled sevoflurane intraoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol, sevoflurane</intervention_name>
    <description>Remifentanil will be infused intraoperatively at 0.2 ㎍/㎏/min (group1 and 2) group 1 (Active Comparator, sevoflurane)will be infused propofol intraoperatively.
group 2(Experimental, propofol) will be inhaled sevoflurane intraoperatively.</description>
    <arm_group_label>sevoflurane</arm_group_label>
    <arm_group_label>propofol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing thyroidectomy

          -  Age 20-65

          -  American Society of Anesthesiologists physical status classification I or II

        Exclusion Criteria:

          -  History of chronic pain, Regular use of analgesic, antiepileptic or antidepressive
             drugs

          -  History of drug &amp; alcohol abuse

          -  Psychiatric disorder

          -  Use of opioids within 24hrs

          -  Renal disease with decreased glomerular filtrate ratio

          -  Neuromuscular disease, Severe cardiac disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>yuen hee shim, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Gangnam severance hospital, Yonsei university, Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Reseach Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>young ju won, MD.</last_name>
    <phone>082-2-2019-6805</phone>
    <email>moma2@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>yuen hee shim, MD.</last_name>
    <phone>082-2-2019-6808</phone>
    <email>tren125@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gang Nam Severance Hospital, Yonsei University, Anesthesia and Pain Medicine Department,</name>
      <address>
        <city>Seoul</city>
        <zip>135-270</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>young ju won, MD</last_name>
      <phone>082-2-2019-6805</phone>
      <email>moma2@naver.com</email>
    </contact>
    <investigator>
      <last_name>young ju won, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2010</study_first_submitted>
  <study_first_submitted_qc>August 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2010</study_first_posted>
  <last_update_submitted>August 26, 2010</last_update_submitted>
  <last_update_submitted_qc>August 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Gang nam Severance Hospital, Anesthesia and Pain Research Institute</name_title>
    <organization>Anesthesia and Pain Research Institute</organization>
  </responsible_party>
  <keyword>remifentanil</keyword>
  <keyword>hyperalgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

